Product, Regulatory & Reimbursement Strategy

Product, regulatory, and reimbursement strategy connects the technical promise of a solution to the practical requirements needed for use in real-world settings. A product may begin as a research aim, prototype, dataset, assay, device, software tool, or platform capability, but commercialization requires translating that work into a defined offering with clear users, intended use, requirements, evidence needs, and adoption assumptions.

Product strategy begins with specificity. Teams need to clarify what the product actually is, who will use it, what workflow it fits into, what claims can be supported, and what performance expectations must be met. This step helps prevent the common problem of building technology before defining the commercial use case.

Regulatory considerations also need to be identified early, especially for medical devices, diagnostics, digital health tools, Al-enabled decision support, clinical software, research tools, and products used in controlled or safety-sensitive environments. Even when a formal regulatory submission is not immediately required, understanding likely pathways, documentation expectations, risk controls, and evidence standards can shape better development decisions.

Reimbursement and payment assumptions are equally important. A solution may be valuable to users but difficult to adopt if the buyer, payer, budget holder, or procurement pathway is unclear. Teams should consider whether value will be justified through clinical outcomes, operational savings, revenue generation, risk reduction, productivity gains, or strategic differentiation.

At this stage, the goal is not to resolve every regulatory or payment question. The goal is to identify the most important unknowns, document reasonable assumptions, and build a development plan that supports future pilots, funding applications, partner discussions, and commercialization decisions.